General Information of Drug (ID: DMFV76H)

Drug Name
(2-fluorophenyl)-(4-fluorophenyl)phenylacetamide
Synonyms CHEMBL42205; (2-fluorophenyl)-(4-fluorophenyl)phenylacetamide; SCHEMBL1443821; UFALWTGZIJAUPP-UHFFFAOYSA-N; BDBM50099566; ICA-15451; (2-fluorophenyl)-(4 fluorophenyl)phenylacetamide
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 323.3
Logarithm of the Partition Coefficient (xlogp) 4.1
Rotatable Bond Count (rotbonds) 4
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C20H15F2NO
IUPAC Name
2-(2-fluorophenyl)-2-(4-fluorophenyl)-2-phenylacetamide
Canonical SMILES
C1=CC=C(C=C1)C(C2=CC=C(C=C2)F)(C3=CC=CC=C3F)C(=O)N
InChI
InChI=1S/C20H15F2NO/c21-16-12-10-15(11-13-16)20(19(23)24,14-6-2-1-3-7-14)17-8-4-5-9-18(17)22/h1-13H,(H2,23,24)
InChIKey
UFALWTGZIJAUPP-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
9966986
TTD ID
D06XXG

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Calcium-activated potassium channel (KCN) TTMNI76 NOUNIPROTAC Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Novel inhibitors of the Gardos channel for the treatment of sickle cell disease. J Med Chem. 2008 Feb 28;51(4):976-82.